BD PharmingenTM FITC Rat Anti-Mouse Vbeta4 T-Cell Receptor

Description

Two-color analysis of the expression of Vbeta4 TCR on peripheral T lymphocytes. C57BL/6 lymph node cells were incubated simultaneously with FITC-conjugated KT4, PE-conjugated RM4-5 anti-CD4, Cat. no. 553048/553049 , and PE-conjugated 53-6.7 anti-CD8a, Cat. no. 553032/553033 monoclonal antibodies. Flow cytometry was performed on a FACScan BDIS, San Jose, CA . Two-color analysis of the expression of Vbeta4 TCR on peripheral T lymphocytes. C57BL/6 lymph node cells were incubated simultaneously with FITC-conjugated KT4, PE-conjugated RM4-5 anti-CD4, Cat. no. 553048/553049 , and PE-conjugated 53-6.7 anti-CD8a, Cat. no. 553032/553033 monoclonal antibodies. Flow cytometry was performed on a FACScan BDIS, San Jose, CA . Show More Two-color analysis of the expression of Vbeta4 TCR on peripheral T lymphocytes. C57BL/6 lymph node cells were incubated simultaneously with FITC-conjugated KT4, PE-conjugated RM4-5 anti-CD4, Cat. no. 553048/553049 , and PE-conjugated 53-6.7 anti-CD8a, Cat. no. 553032/553033 monoclonal antibodies. Flow cytometry was performed on a FACScan BDIS, San Jose, CA .